Megestrol Acetate for Prevention of Weight Loss During Modern Radiotherapy in Patients With Head and Neck Cancer: A Multicenter Randomized Controlled Trial
Pooriwat Muangwong,
Vatanyu Samakgarn,
Panlop Malasri,
Piyapasara Toapichattrakul,
Imjai Chitapanarux Head and Neck
· Wiley
· 2026-11-19
· DOI: 10.1002/hed.70558
Аннотация
ABSTRACT Background Weight loss is a common complication during radiotherapy for head and neck cancer and may adversely affect treatment tolerance and outcomes. We evaluated whether megestrol acetate (MA) prevents treatment‐related weight loss. Methods In this multicenter, open‐label randomized controlled trial, 102 patients with non‐nasopharyngeal head and neck squamous cell carcinoma undergoing radiotherapy were assigned to MA plus standard care or standard care alone. Standard care consisted of nutritional counseling, symptom management, and feeding‐tube placement when clinically indicated. The primary endpoint was change in body weight from baseline to 6 weeks post‐radiotherapy. Results At 6 weeks post‐radiotherapy, the MA group showed a mean weight gain of 2.07 kg, whereas the control group lost 1.74 kg ( p < 0.01). Weight gain was primarily due to increased fat mass, with no significant difference in muscle mass. Quality of life was similar between groups. Conclusion MA improved weight preservation during radiotherapy and may serve as an adjunct to supportive care in head and neck cancer. Trial Registration ClinicalTrials.gov identifier: TCTR20240330005
Pooriwat Muangwong, Vatanyu Samakgarn, Panlop Malasri, Piyapasara Toapichattrakul, Imjai Chitapanarux. Megestrol Acetate for Prevention of Weight Loss During Modern Radiotherapy in Patients With Head and Neck Cancer: A Multicenter Randomized Controlled Trial. // Head and Neck. – 2026. – DOI: 10.1002/hed.70558. – URL: https://onlinelibrary.wiley.com/doi/10.1002/hed.70558?af=R
Pooriwat Muangwong, Vatanyu Samakgarn, Panlop Malasri, Piyapasara Toapichattrakul, & Imjai Chitapanarux (2026). Megestrol Acetate for Prevention of Weight Loss During Modern Radiotherapy in Patients With Head and Neck Cancer: A Multicenter Randomized Controlled Trial. Head and Neck. https://doi.org/10.1002/hed.70558
Pooriwat Muangwong, et al. “Megestrol Acetate for Prevention of Weight Loss During Modern Radiotherapy in Patients With Head and Neck Cancer: A Multicenter Randomized Controlled Trial.” Head and Neck, 2026. doi:10.1002/hed.70558.
@article{Muangwong2026,
title = {Megestrol Acetate for Prevention of Weight Loss During Modern Radiotherapy in Patients With Head and Neck Cancer: A Multicenter Randomized Controlled Trial},
author = {Muangwong, Pooriwat and Samakgarn, Vatanyu and Malasri, Panlop and Toapichattrakul, Piyapasara and Chitapanarux, Imjai},
journal = {Head and Neck},
year = {2026},
doi = {10.1002/hed.70558},
url = {https://onlinelibrary.wiley.com/doi/10.1002/hed.70558?af=R}
}
ABSTRACT Objective This study aimed to adapt the Oral Health‐Related Quality of Life for Adolescents with Down Syndrome (OH‐QOLADS) scale into Turkish and evaluate its psychometric properties. It also explored oral health status and...
ABSTRACT Objective To evaluate changes in basal serum cortisol levels in patients with atrophic‐erosive oral lichen planus (OLP) and oral lichenoid lesion (OLL) treated with 0.5% triamcinolone acetonide mouthrinses and to assess the...
ABSTRACT Background Periodontitis is a chronic inflammatory disease initiated by dental plaque biofilm, characterized primarily by dysregulated host immune‐inflammatory responses and progressive alveolar bone resorption, in which the...
ABSTRACT Objective To conduct a systematic review and meta‐analysis of worldwide prevalence of geographic tongue (GT) in healthy children and adolescents. Methods A search was conducted in five main databases (MEDLINE, Web of Science,...